Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Q4 2022 Earnings Call Transcript

Operator: Good morning and welcome to the Inhibikase Fourth Quarter and Full Year 2022 Earnings Conference Call. Please note, today's event is being recorded.

Keep Reading →